231 related articles for article (PubMed ID: 20831504)
1. The role of protons in modern and biologically-guided radiotherapy.
Nyström H
Acta Oncol; 2010 Oct; 49(7):1124-31. PubMed ID: 20831504
[TBL] [Abstract][Full Text] [Related]
2. Optimization of physical dose distributions with hadron beams: comparing photon IMRT with IMPT.
Oelfke U; Bortfeld T
Technol Cancer Res Treat; 2003 Oct; 2(5):401-12. PubMed ID: 14529305
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
5. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
Baumert BG; Norton IA; Lomax AJ; Davis JB
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
[TBL] [Abstract][Full Text] [Related]
6. Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements?
Ares C; Khan S; Macartain AM; Heuberger J; Goitein G; Gruber G; Lutters G; Hug EB; Bodis S; Lomax AJ
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):685-97. PubMed ID: 19615828
[TBL] [Abstract][Full Text] [Related]
7. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
[TBL] [Abstract][Full Text] [Related]
8. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
9. Dose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques.
Purdy JA
Health Phys; 2008 Nov; 95(5):666-76. PubMed ID: 18849701
[TBL] [Abstract][Full Text] [Related]
10. Treatment planning for conformal proton radiation therapy.
Bussière MR; Adams JA
Technol Cancer Res Treat; 2003 Oct; 2(5):389-99. PubMed ID: 14529304
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiation therapy - you can have your cake and eat it too!
Mohan R
Med Phys; 2023 Jun; 50 Suppl 1():74-79. PubMed ID: 36377546
[TBL] [Abstract][Full Text] [Related]
12. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.
Nichols RC; Huh SN; Prado KL; Yi BY; Sharma NK; Ho MW; Hoppe BS; Mendenhall NP; Li Z; Regine WF
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):158-63. PubMed ID: 22245197
[TBL] [Abstract][Full Text] [Related]
13. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
[TBL] [Abstract][Full Text] [Related]
14. Developments in radiotherapy.
Svensson H; Möller TR;
Acta Oncol; 2003; 42(5-6):430-42. PubMed ID: 14596505
[TBL] [Abstract][Full Text] [Related]
15. Intensity modulated photon and proton therapy for the treatment of head and neck tumors.
Steneker M; Lomax A; Schneider U
Radiother Oncol; 2006 Aug; 80(2):263-7. PubMed ID: 16916557
[TBL] [Abstract][Full Text] [Related]
16. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.
Roelofs E; Engelsman M; Rasch C; Persoon L; Qamhiyeh S; de Ruysscher D; Verhaegen F; Pijls-Johannesma M; Lambin P;
J Thorac Oncol; 2012 Jan; 7(1):165-76. PubMed ID: 22071782
[TBL] [Abstract][Full Text] [Related]
17. Prioritized optimization in intensity modulated proton therapy.
Falkinger M; Schell S; Müller J; Wilkens JJ
Z Med Phys; 2012 Feb; 22(1):21-8. PubMed ID: 21723105
[TBL] [Abstract][Full Text] [Related]
18. The impact of IMRT and proton radiotherapy on secondary cancer incidence.
Schneider U; Lomax A; Pemler P; Besserer J; Ross D; Lombriser N; Kaser-Hotz B
Strahlenther Onkol; 2006 Nov; 182(11):647-52. PubMed ID: 17072522
[TBL] [Abstract][Full Text] [Related]
19. Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma.
Madani I; Lomax AJ; Albertini F; Trnková P; Weber DC
Radiat Oncol; 2015 Mar; 10():72. PubMed ID: 25890217
[TBL] [Abstract][Full Text] [Related]
20. Proton therapy in the clinic.
DeLaney TF
Front Radiat Ther Oncol; 2011; 43():465-485. PubMed ID: 21625169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
